Delivery Order SPE2DB20D2104-SPE2DB23FS69E

Award Date 3/20/23
Potential Completion Date 3/21/23
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $10,253.17, is for the delivery of Lamictal XR 25 mg tablets, a prescription medication used to treat epilepsy and bipolar disorder. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,470.18 firm fixed-price delivery order is for the supply of Lamictal XR 200 mg tablets, a medication used to treat epilepsy and certain types of mental health conditions. The award is not designated as a set-aside contract. It is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $1,531.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lamictal XR 50 mg tablets, a prescription medication used to treat certain types of seizures and bipolar disorder. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to...
This is a $5,928.75 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 300 mg Lamictal XR tablets. The contract has a period of performance through July 13, 2022. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LAMICTAL XR 250 MG TABLET 30S. The $13,637.86 firm fixed price contract has an ultimate completion date of October 23, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lamictal XR 100 mg tablets. The $3,695.24 firm-fixed-price contract has an ultimate completion date of August 14, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lamictal XR 100 mg tablets. The firm-fixed-price contract has a ceiling value of $5,814.13 and a completion date of June 22, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which covers a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,038.01, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of Lamictal XR 200 mg tablets. The contract is a delivery order that falls under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $20,539.31, is for the delivery of Lamictal XR 300 mg tablets to support defense and civilian medical programs. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen. This IDC, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,832.65, is for the provision of LAMICTAL XR 300 MG TABLET 30S, a prescription medication. The contract is a Firm Fixed Price Delivery Order with a completion date of December 9, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB23FS69E
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,445.64 firm fixed-price contract is for the supply of Lamictal XR 300 mg tablets, a prescription medication used to treat epilepsy and bipolar disorder.

The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC, which runs through November 2026, enables efficient government procurement of essential medications and medical commodities across multiple therapeutic areas.

The contract does not have a set-aside designation, indicating it was competitively awarded. As a major supplier to federal healthcare programs, particularly within the military and veterans' healthcare systems, AmerisourceBergen has established itself as a key vendor for the DLA and other government agencies in providing critical pharmaceutical and medical products.

Generated 2/27/25, 11:00 AM